tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of John Sourbeer, 37 are a BUY (50.68%), 35 are a HOLD (47.95%), 1 are a SELL (1.37%).
Analyst John Sourbeer, currently employed at UBS, carries an average stock price target met ratio of 47.81% that have a potential upside of 8.98% achieved within 56 days.
John Sourbeer’s has documented 150 price targets and ratings displayed on 19 stocks. The coverage is on Healthcare, Industrials, Basic Materials sectors.
Most recent stock forecast was given on PACB, Pacific Biosciences of California at 11-Nov-2024.
Analyst best performing recommendations are on OCDX (ORTHO CLINICAL DIAGNOSTICS HOLDINGS PLC).
The best stock recommendation documented was for PACB (PACIFIC BIOSCIENCES OF CALIFORNIA) at 11/11/2024. The price target of $2 was fulfilled within 2 days with a profit of $0.35 (14.89%) receiving and performance score of 74.47.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Hold
$18.19
$0.56 (3.18%)
$24
2 years 6 months 18 days ago
(06-May-2022)
0/2 (0%)
$0.83 (4.78%)
Hold
$20
$2.37 (13.44%)
$25
2 years 9 months 7 days ago
(17-Feb-2022)
0/6 (0%)
$3.83 (23.69%)
Hold
$17
$-0.63 (-3.57%)
$28
2 years 9 months 8 days ago
(17-Feb-2022)
1/3 (33.33%)
$0.83 (5.13%)
1
Buy
$21
$3.37 (19.12%)
2 years 9 months 8 days ago
(17-Feb-2022)
0/3 (0%)
$4.83 (29.87%)
Hold
$24.68
$7.05 (39.99%)
$24.68
2 years 10 months 25 days ago
(31-Dec-2021)
0/2 (0%)
$3.29 (15.38%)
Which stock is John Sourbeer is most bullish on?
Which stock is John Sourbeer is most reserved on?
What Year was the first public recommendation made by John Sourbeer?
